{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:27:05Z","timestamp":1795033625817,"version":"4.10.2"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7997","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Guillain\u2013Barr\u00e9 syndrome (GBS) is a rare heterogenous disorder of the peripheral nervous system, which is usually triggered by a preceding infection, and causes a potentially\u00a0life-threatening\u00a0progressive muscle weakness\n                    <jats:sup>1<\/jats:sup>\n                    . Although GBS is considered an autoimmune disease, the mechanisms that underlie its distinct clinical subtypes remain largely unknown. Here, by combining in vitro T cell screening, single-cell RNA sequencing and T cell receptor\u00a0(TCR) sequencing, we identify autoreactive memory CD4\n                    <jats:sup>+<\/jats:sup>\n                    cells,\u00a0that show\u00a0a cytotoxic T helper 1 (T\n                    <jats:sub>H<\/jats:sub>\n                    1)-like phenotype, and rare CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells that target myelin antigens of the peripheral nerves in patients with the demyelinating disease variant. We characterized more than 1,000 autoreactive single T cell clones, which revealed a polyclonal TCR repertoire, short CDR3\u03b2 lengths, preferential HLA-DR restrictions and recognition of immunodominant epitopes. We found that autoreactive TCR\u03b2 clonotypes were expanded in the blood\u00a0of the same patient at distinct disease stages\u00a0and, notably, that they were shared in\u00a0the blood and the cerebrospinal fluid across different patients with GBS, but not in control individuals. Finally, we identified myelin-reactive T cells in the nerve biopsy from one patient, which indicates that these cells contribute directly to disease pathophysiology. Collectively, our data provide clear\u00a0evidence of autoreactive T cell\u00a0immunity in a subset of patients with GBS, and open new perspectives in the field of inflammatory\u00a0peripheral neuropathies, with potential impact for\u00a0biomedical applications.\n                  <\/jats:p>","DOI":"10.1038\/s41586-023-06916-6","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T11:13:13Z","timestamp":1705489993000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Autoreactive T cells target peripheral nerves in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1038","volume":"626","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-1609","authenticated-orcid":false,"given":"L.","family":"S\u00faken\u00edkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-9718","authenticated-orcid":false,"given":"A.","family":"Mallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-9656","authenticated-orcid":false,"given":"P.","family":"Ripellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-5817","authenticated-orcid":false,"given":"M.","family":"Stoffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Ulbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-1534","authenticated-orcid":false,"given":"D.","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"6916_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila, N., Lehmann, H. C. & Kuwabara, S. Guillain\u2013Barr\u00e9 syndrome. Lancet 397, 1214\u20131228 (2021).","journal-title":"Lancet"},{"key":"6916_CR2","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","volume":"141","author":"AY Doets","year":"2018","unstructured":"Doets, A. Y. et al. Regional variation of Guillain\u2013Barr\u00e9 syndrome. Brain 141, 2866\u20132877 (2018).","journal-title":"Brain"},{"key":"6916_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain\u2013Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"6916_CR4","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","volume":"27","author":"M Patone","year":"2021","unstructured":"Patone, M. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 27, 2144\u20132153 (2021).","journal-title":"Nat. Med."},{"key":"6916_CR5","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/brain\/awab279","volume":"144","author":"LWG Luijten","year":"2021","unstructured":"Luijten, L. W. G. et al. Guillain\u2013Barr\u00e9 syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain 144, 3392\u20133404 (2021).","journal-title":"Brain"},{"key":"6916_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jneuroim.2018.07.016","volume":"323","author":"S Blum","year":"2018","unstructured":"Blum, S. et al. Genome-wide association study in Guillain\u2013Barr\u00e9 syndrome. J. Neuroimmunol. 323, 109\u2013114 (2018).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","volume":"64","author":"K Geleijns","year":"2005","unstructured":"Geleijns, K. et al. HLA class II alleles are not a general susceptibility factor in Guillain\u2013Barr\u00e9 syndrome. Neurology 64, 44\u201349 (2005).","journal-title":"Neurology"},{"key":"6916_CR8","doi-asserted-by":"publisher","first-page":"102665","DOI":"10.1016\/j.autrev.2020.102665","volume":"19","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Zhu, R., Tian, D. & Liu, X. Genetic polymorphisms in Guillain\u2013Barr\u00e9 syndrome: a field synopsis and systematic meta-analysis. Autoimmun. Rev. 19, 102665 (2020).","journal-title":"Autoimmun. Rev."},{"key":"6916_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mus.20762","volume":"35","author":"N Yuki","year":"2007","unstructured":"Yuki, N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35, 691\u2013711 (2007).","journal-title":"Muscle Nerve"},{"key":"6916_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.it.2022.02.003","volume":"43","author":"JD Laman","year":"2022","unstructured":"Laman, J. D., Huizinga, R., Boons, G. J. & Jacobs, B. C. Guillain\u2013Barr\u00e9 syndrome: expanding the concept of molecular mimicry. Trends Immunol. 43, 296\u2013308 (2022).","journal-title":"Trends Immunol."},{"key":"6916_CR11","unstructured":"Morell, P. Q. & Quarles, R. H. in Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edn (eds Siegel, G. J. et al.) Ch. 4 (Lippincott-Raven, 1999)."},{"key":"6916_CR12","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/brain\/awg207","volume":"126","author":"J Wanschitz","year":"2003","unstructured":"Wanschitz, J., Maier, H., Lassmann, H., Budka, H. & Berger, T. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain\u2013Barr\u00e9 syndrome. Brain 126, 2034\u20132042 (2003).","journal-title":"Brain"},{"key":"6916_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","volume":"19","author":"B Schmidt","year":"1996","unstructured":"Schmidt, B. et al. Inflammatory infiltrates in sural nerve biopsies in Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19, 474\u2013487 (1996).","journal-title":"Muscle Nerve"},{"key":"6916_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0165-5728(89)90095-7","volume":"24","author":"WA Taylor","year":"1989","unstructured":"Taylor, W. A. & Hughes, R. A. T lymphocyte activation antigens in Guillain\u2013Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 24, 33\u201339 (1989).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","volume":"192","author":"LJ Chi","year":"2007","unstructured":"Chi, L. J., Wang, H. B., Zhang, Y. & Wang, W. Z. Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain\u2013Barr\u00e9 syndrome. J. Neuroimmunol. 192, 206\u2013214 (2007).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","volume":"15","author":"J Harness","year":"2008","unstructured":"Harness, J. & McCombe, P. A. Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain\u2013Barr\u00e9 syndrome patients compared to controls. J Clin. Neurosci. 15, 1031\u20131035 (2008).","journal-title":"J Clin. Neurosci."},{"key":"6916_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jneuroim.2006.12.002","volume":"183","author":"J Pritchard","year":"2007","unstructured":"Pritchard, J., Makowska, A., Gregson, N. A., Hayday, A. C. & Hughes, R. A. Reduced circulating CD4+CD25+ cell populations in Guillain\u2013Barr\u00e9 syndrome. J. Neuroimmunol. 183, 232\u2013238 (2007).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","volume":"34","author":"RK Han","year":"2014","unstructured":"Han, R. K. et al. Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain\u2013Barr\u00e9 syndrome. J. Clin. Immunol. 34, 94\u2013103 (2014).","journal-title":"J. Clin. Immunol."},{"key":"6916_CR19","first-page":"19126","volume":"8","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. Expression and significance of CD4+CD25+CD127\u2212 regulatory T cells in peripheral blood of patients with different phenotypes of Guillain\u2013Barr\u00e9 syndrome. Int. J. Clin. Exp. Med. 8, 19126\u201319131 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"6916_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep20963","volume":"6","author":"Y Che","year":"2016","unstructured":"Che, Y. et al. Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain\u2013Barr\u00e9 syndrome. Sci. Rep. 6, 20963 (2016).","journal-title":"Sci. Rep."},{"key":"6916_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-5728(94)90032-9","volume":"53","author":"C Dahle","year":"1994","unstructured":"Dahle, C., Vrethem, M. & Ernerudh, J. T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain\u2013Barr\u00e9 syndrome. J. Neuroimmunol. 53, 219\u2013225 (1994).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0022-510X(92)90069-W","volume":"111","author":"A Khalili-Shirazi","year":"1992","unstructured":"Khalili-Shirazi, A., Hughes, R. A., Brostoff, S. W., Linington, C. & Gregson, N. T cell responses to myelin proteins in Guillain\u2013Barr\u00e9 syndrome. J. Neurol. Sci. 111, 200\u2013203 (1992).","journal-title":"J. Neurol. Sci."},{"key":"6916_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0022-510X(91)90215-S","volume":"104","author":"WA Taylor","year":"1991","unstructured":"Taylor, W. A., Brostoff, S. W. & Hughes, R. A. P2 specific lymphocyte transformation in Guillain\u2013Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neurol. Sci. 104, 52\u201355 (1991).","journal-title":"J. Neurol. Sci."},{"key":"6916_CR24","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","volume":"76","author":"PA Csurhes","year":"2005","unstructured":"Csurhes, P. A., Sullivan, A. A., Green, K., Pender, M. P. & McCombe, P. A. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neurol. Neurosurg. Psychiatry 76, 1431\u20131439 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"6916_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield, M. L., George, L. K., Grant, G. D. & Perou, C. M. Common markers of proliferation. Nat. Rev. Cancer 6, 99\u2013106 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"6916_CR26","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1101\/gr.192237.115","volume":"25","author":"MS Kowalczyk","year":"2015","unstructured":"Kowalczyk, M. S. et al. Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. 25, 1860\u20131872 (2015).","journal-title":"Genome Res."},{"key":"6916_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/eji.202048630","volume":"51","author":"A Cassotta","year":"2021","unstructured":"Cassotta, A. et al. Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naive repertoire and are clonally expanded in the memory repertoire. Eur. J. Immunol. 51, 648\u2013661 (2021).","journal-title":"Eur. J. Immunol."},{"key":"6916_CR28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.abg8985","volume":"372","author":"JS Low","year":"2021","unstructured":"Low, J. S. et al. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science 372, 1336\u20131341 (2021).","journal-title":"Science"},{"key":"6916_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"6916_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01925-2","volume":"8","author":"I Gomez-Tourino","year":"2017","unstructured":"Gomez-Tourino, I., Kamra, Y., Baptista, R., Lorenc, A. & Peakman, M. T cell receptor \u03b2-chains display abnormal shortening and repertoire sharing in type 1 diabetes. Nat. Commun. 8, 1792 (2017).","journal-title":"Nat. Commun."},{"key":"6916_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11153","volume":"7","author":"T Schneider-Hohendorf","year":"2016","unstructured":"Schneider-Hohendorf, T. et al. CD8+ T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. Nat. Commun. 7, 11153 (2016).","journal-title":"Nat. Commun."},{"key":"6916_CR32","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"6916_CR33","doi-asserted-by":"publisher","unstructured":"Chour, W. et al. Shared antigen-specific CD8+ T cell responses against the SARS-COV-2 spike protein in HLA-A*02:01 COVID-19 participants. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.05.04.20085779 (2020).","DOI":"10.1101\/2020.05.04.20085779"},{"key":"6916_CR34","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gkx760","volume":"46","author":"M Shugay","year":"2018","unstructured":"Shugay, M. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46, D419\u2013D427 (2018).","journal-title":"Nucleic Acids Res."},{"key":"6916_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18137-9","volume":"7","author":"DA Yohannes","year":"2017","unstructured":"Yohannes, D. A. et al. Deep sequencing of blood and gut T-cell receptor \u03b2-chains reveals gluten-induced immune signatures in celiac disease. Sci. Rep. 7, 17977 (2017).","journal-title":"Sci. Rep."},{"key":"6916_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/ecco-jcc\/jjz179","volume":"14","author":"E Rosati","year":"2020","unstructured":"Rosati, E. et al. Identification of disease-associated traits and clonotypes in the T cell receptor repertoire of monozygotic twins affected by inflammatory bowel diseases. J. Crohns Colitis 14, 778\u2013790 (2020).","journal-title":"J. Crohns Colitis"},{"key":"6916_CR37","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"6916_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/biof.1076","volume":"39","author":"H Han","year":"2013","unstructured":"Han, H., Myllykoski, M., Ruskamo, S., Wang, C. & Kursula, P. Myelin-specific proteins: a structurally diverse group of membrane-interacting molecules. Biofactors 39, 233\u2013241 (2013).","journal-title":"Biofactors"},{"key":"6916_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37009-4","volume":"9","author":"A Raasakka","year":"2019","unstructured":"Raasakka, A. et al. Molecular structure and function of myelin protein P0 in membrane stacking. Sci. Rep. 9, 642 (2019).","journal-title":"Sci. Rep."},{"key":"6916_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/brain\/awh048","volume":"127","author":"ME Shy","year":"2004","unstructured":"Shy, M. E. et al. Phenotypic clustering in MPZ mutations. Brain 127, 371\u2013384 (2004).","journal-title":"Brain"},{"key":"6916_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0960-8966(02)00021-4","volume":"12","author":"VA Street","year":"2002","unstructured":"Street, V. A. et al. Charcot\u2013Marie\u2013Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes. Neuromuscul. Disord. 12, 643\u2013650 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"6916_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s004150170096","volume":"248","author":"V Plante-Bordeneuve","year":"2001","unstructured":"Plante-Bordeneuve, V. et al. The range of chronic demyelinating neuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases. J. Neurol. 248, 795\u2013803 (2001).","journal-title":"J. Neurol."},{"key":"6916_CR43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1084\/jem.194.5.677","volume":"194","author":"B Salomon","year":"2001","unstructured":"Salomon, B. et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194, 677\u2013684 (2001).","journal-title":"J. Exp. Med."},{"key":"6916_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1084\/jem.20082113","volume":"206","author":"C Louvet","year":"2009","unstructured":"Louvet, C. et al. A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy. J. Exp. Med. 206, 507\u2013514 (2009).","journal-title":"J. Exp. Med."},{"key":"6916_CR45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/1074-7613(95)90068-3","volume":"3","author":"MA Gavin","year":"1995","unstructured":"Gavin, M. A. & Bevan, M. J. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 3, 793\u2013800 (1995).","journal-title":"Immunity"},{"key":"6916_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri2260","volume":"8","author":"V Venturi","year":"2008","unstructured":"Venturi, V., Price, D. A., Douek, D. C. & Davenport, M. P. The molecular basis for public T-cell responses? Nat. Rev. Immunol. 8, 231\u2013238 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"6916_CR47","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","volume":"25","author":"G Lucchese","year":"2020","unstructured":"Lucchese, G. & Floel, A. SARS-CoV-2 and Guillain\u2013Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones 25, 731\u2013735 (2020).","journal-title":"Cell Stress Chaperones"},{"key":"6916_CR48","doi-asserted-by":"publisher","first-page":"674922","DOI":"10.3389\/fimmu.2021.674922","volume":"12","author":"S Shoraka","year":"2021","unstructured":"Shoraka, S., Ferreira, M. L. B., Mohebbi, S. R. & Ghaemi, A. SARS-CoV-2 infection and Guillain\u2013Barr\u00e9 syndrome: a review on potential pathogenic mechanisms. Front. Immunol. 12, 674922 (2021).","journal-title":"Front. Immunol."},{"key":"6916_CR49","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/eji.202149475","volume":"52","author":"D Latorre","year":"2022","unstructured":"Latorre, D. Autoimmunity and SARS-CoV-2 infection: unraveling the link in neurological disorders. Eur. J. Immunol. 52, 1561\u20131571 (2022).","journal-title":"Eur. J. Immunol."},{"key":"6916_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","volume":"64","author":"R Kiefer","year":"2001","unstructured":"Kiefer, R., Kieseier, B. C., Stoll, G. & Hartung, H. P. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 64, 109\u2013127 (2001).","journal-title":"Prog. Neurobiol."},{"key":"6916_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/glia.20903","volume":"58","author":"G Meyer Zu Horste","year":"2010","unstructured":"Meyer Zu Horste, G. et al. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia 58, 80\u201392 (2010).","journal-title":"Glia"},{"key":"6916_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12744-2","volume":"7","author":"M Hartlehnert","year":"2017","unstructured":"Hartlehnert, M. et al. Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II. Sci. Rep. 7, 12518 (2017).","journal-title":"Sci. Rep."},{"key":"6916_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.nbd.2009.11.006","volume":"37","author":"G Meyer zu Horste","year":"2010","unstructured":"Meyer zu Horste, G. et al. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Neurobiol. Dis. 37, 483\u2013490 (2010).","journal-title":"Neurobiol. Dis."},{"key":"6916_CR54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/jnen\/60.6.637","volume":"60","author":"JM Taylor","year":"2001","unstructured":"Taylor, J. M. & Pollard, J. D. Dominance of autoreactive T cell-mediated delayed-type hypersensitivity or antibody-mediated demyelination results in distinct forms of experimental autoimmune neuritis in the Lewis rat. J. Neuropathol. Exp. Neurol. 60, 637\u2013646 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"6916_CR55","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1002\/ana.410270713","volume":"27","author":"RH Quarles","year":"1990","unstructured":"Quarles, R. H., Ilyas, A. A. & Willison, H. J. Antibodies to gangliosides and myelin proteins in Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 27, S48\u2013S52 (1990).","journal-title":"Ann. Neurol."},{"key":"6916_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0165-5728(93)90255-W","volume":"46","author":"A Khalili-Shirazi","year":"1993","unstructured":"Khalili-Shirazi, A., Atkinson, P., Gregson, N. & Hughes, R. A. Antibody responses to P0 and P2 myelin proteins in Guillain\u2013Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 46, 245\u2013251 (1993).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","volume":"10","author":"D Allen","year":"2005","unstructured":"Allen, D. et al. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 10, 174\u2013180 (2005).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"6916_CR58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","volume":"78","author":"HR Inglis","year":"2007","unstructured":"Inglis, H. R., Csurhes, P. A. & McCombe, P. A. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J. Neurol. Neurosurg. Psychiatry 78, 419\u2013422 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"6916_CR59","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","volume":"79","author":"A Makowska","year":"2008","unstructured":"Makowska, A. et al. Immune responses to myelin proteins in Guillain\u2013Barr\u00e9 syndrome. J. Neurol. Neurosurg. Psychiatry 79, 664\u2013671 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"6916_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-5728(99)00269-6","volume":"104","author":"CM Gabriel","year":"2000","unstructured":"Gabriel, C. M., Gregson, N. A. & Hughes, R. A. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J. Neuroimmunol. 104, 139\u2013146 (2000).","journal-title":"J. Neuroimmunol."},{"key":"6916_CR61","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury, A. K. & Cornblath, D. R. Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome. Ann. Neurol. 27, S21\u2013S24 (1990).","journal-title":"Ann. Neurol."},{"key":"6916_CR62","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1099\/vir.0.83523-0","volume":"89","author":"G Gerna","year":"2008","unstructured":"Gerna, G. et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection. J. Gen. Virol. 89, 853\u2013865 (2008).","journal-title":"J. Gen. Virol."},{"key":"6916_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15543-y","volume":"11","author":"E Cano-Gamez","year":"2020","unstructured":"Cano-Gamez, E. et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines. Nat. Commun. 11, 1801 (2020).","journal-title":"Nat. Commun."},{"key":"6916_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12464-3","volume":"10","author":"PA Szabo","year":"2019","unstructured":"Szabo, P. A. et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat. Commun. 10, 4706 (2019).","journal-title":"Nat. Commun."},{"key":"6916_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.immuni.2019.05.014","volume":"51","author":"CA Tibbitt","year":"2019","unstructured":"Tibbitt, C. A. et al. Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells. Immunity 51, 169\u2013184 (2019).","journal-title":"Immunity"},{"key":"6916_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/intimm\/13.3.367","volume":"13","author":"S Nagai","year":"2001","unstructured":"Nagai, S. et al. Comprehensive gene expression profile of human activated Th1- and Th2-polarized cells. Int. Immunol. 13, 367\u2013376 (2001).","journal-title":"Int. Immunol."},{"key":"6916_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01571-8","volume":"8","author":"D Hu","year":"2017","unstructured":"Hu, D. et al. Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat. Commun. 8, 1600 (2017).","journal-title":"Nat. Commun."},{"key":"6916_CR68","doi-asserted-by":"publisher","first-page":"e000162","DOI":"10.1136\/jitc-2019-000162","volume":"8","author":"M Eckstein","year":"2020","unstructured":"Eckstein, M. et al. Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy. J. Immunother. Cancer 8, e000162 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"6916_CR69","doi-asserted-by":"publisher","first-page":"eabi9591","DOI":"10.1126\/science.abi9591","volume":"376","author":"J Li","year":"2022","unstructured":"Li, J. et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376, eabi9591 (2022).","journal-title":"Science"},{"key":"6916_CR70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","volume":"4","author":"N Borcherding","year":"2021","unstructured":"Borcherding, N. et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun. Biol. 4, 122 (2021).","journal-title":"Commun. Biol."},{"key":"6916_CR71","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06916-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T01:03:02Z","timestamp":1707008582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06916-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":71,"journal-issue":{"issue":"7997","published-print":{"date-parts":[[2024,2,1]]}},"alternative-id":["6916"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06916-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2700548\/v1","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests. P.R. is a member of the advisory boards for Roche, Biogen, Alexion and Argenx Pharmaceuticals, all of which are not connected to this project.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}